IPHA vs AMGN: Which Stock is Better?
Side-by-side comparison of Innate Pharma Sa and Amgen Inc in 2026
IPHA
Innate Pharma Sa
$1.69
AMGN
Amgen Inc
$348.22
Key Metrics Comparison
| Metric | IPHA | AMGN | Winner |
|---|---|---|---|
| Market Cap | $152.94M | $189.19B | AMGN |
| P/E Ratio | N/A | 24.70 | AMGN |
| EPS (TTM) | $N/A | $14.21 | AMGN |
| Revenue Growth | -0.5% | 0.1% | AMGN |
| Gross Margin | -384.4% | 70.8% | AMGN |
Analyze IPHA
Full quant analysis
Analyze AMGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is IPHA or AMGN a better investment?
Comparing IPHA and AMGN: Innate Pharma Sa has a market cap of $152.94M while Amgen Inc has $189.19B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between IPHA and AMGN?
IPHA (Innate Pharma Sa) and AMGN (Amgen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: IPHA or AMGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: IPHA or AMGN?
AMGN has higher revenue growth at 0.1% vs -0.5% for IPHA.
Which company is more profitable: IPHA or AMGN?
Amgen Inc (AMGN) has higher gross margins at 70.8% compared to -384.4% for IPHA.
Which is the larger company: IPHA or AMGN?
Amgen Inc (AMGN) is larger with a market cap of $189.19B compared to $152.94M for IPHA.
Should I buy IPHA or AMGN in 2026?
Both IPHA and AMGN have investment merit. IPHA trades at $1.69 while AMGN trades at $348.22. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between IPHA and AMGN stock?
Key differences: Market Cap ($152.94M vs $189.19B), P/E Ratio (N/A vs 24.7x), Revenue Growth (-0.5% vs 0.1%), Gross Margin (-384.4% vs 70.8%).